Skip to main content
. 2021 Oct 23;10(11):1294. doi: 10.3390/antibiotics10111294

Figure 1.

Figure 1

In plasma, molnupiravir is rapidly converted to EIDD-1931, which is converted into EIDD-1931-triphosphate, the active antiviral compound, after penetration into SARS-CoV-2-infected cells.